Evidence map›Paper›PMID 41156067›Full record

ArticleJournal of clinical medicine2025

Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results.

Michael Hafner, Tina R Herold, Alexander Kufner, Franziska Eckardt, Ben Asani, Siegfried G Priglinger, Johannes Schiefelbein

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Faricimab: current evidence for the treatment of retinal vein occlusion.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael HafnerDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0009-0008-9025-259X
Tina R HeroldDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
Alexander KufnerDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
Franziska EckardtDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0001-5883-2529
Ben AsaniDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
Siegfried G PriglingerDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0002-5580-612X
Johannes SchiefelbeinDepartment of Ophthalmology, LMU University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0001-5357-7469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiopoietin-2faricimabintravitreal therapymacular edemaoptical coherence tomographyretinal vein occlusionVEGF

Identifiers

PMID41156067
PMCPMC12565708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.